<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>李进医生团队 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-07T20:43:57+08:00</updated>
  <subtitle>科普宣传，患者教育。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>谈笑间丨医之大者，为国为民——马军教授：从一穷二白到世界前沿，栉风沐雨五十载，终不负“医生”之名</title>
    <updated>2020-12-07T17:02:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ykLGf99NmywMfCp9AE7zUA</id>
    <link href="https://mp.weixin.qq.com/s/ykLGf99NmywMfCp9AE7zUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干扰素的前世今生</title>
    <updated>2020-12-04T12:28:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/ybe8otQ2b6d8ua7kBIkb9Q</id>
    <link href="https://mp.weixin.qq.com/s/ybe8otQ2b6d8ua7kBIkb9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>没力气、不想动，癌性疲乏有哪些缓解小妙招？</title>
    <updated>2020-12-04T12:26:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/RSutvKAGOf8xf61jetFB2w</id>
    <link href="https://mp.weixin.qq.com/s/RSutvKAGOf8xf61jetFB2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张雪梅教授：肿瘤患者所关注的治疗相关疑问解答（下）</title>
    <updated>2020-12-01T16:53:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/Ua7wtOjXn4M66dhNe17PRA</id>
    <link href="https://mp.weixin.qq.com/s/Ua7wtOjXn4M66dhNe17PRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌路上 你我同在丨很幸运遇见你们，让我不惧癌魔</title>
    <updated>2020-11-26T16:37:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/SIV58nDN2DLaQczZlrdt6g</id>
    <link href="https://mp.weixin.qq.com/s/SIV58nDN2DLaQczZlrdt6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张雪梅教授：肿瘤患者所关注的治疗相关疑问解答（上）</title>
    <updated>2020-11-25T20:44:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/5yjsTFc41vdAvnCMwOEOQA</id>
    <link href="https://mp.weixin.qq.com/s/5yjsTFc41vdAvnCMwOEOQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>令人绝望的癌痛，如何优雅面对？</title>
    <updated>2020-11-18T13:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/ndK9eLqlpxuv5zKZLdZq9Q</id>
    <link href="https://mp.weixin.qq.com/s/ndK9eLqlpxuv5zKZLdZq9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>说说MAPK那点事</title>
    <updated>2020-11-18T13:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/6aMeUzYwl_aJcdozW4XyPg</id>
    <link href="https://mp.weixin.qq.com/s/6aMeUzYwl_aJcdozW4XyPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>郭晔&amp;杨辉教授：靶向治疗破解治疗困局，安罗替尼高效安全优势显著</title>
    <updated>2020-11-17T11:39:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/PhwrPAxZ941G0g-n43u5_g</id>
    <link href="https://mp.weixin.qq.com/s/PhwrPAxZ941G0g-n43u5_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周彩存教授：肺癌患者所关注的治疗相关疑问解答（下）</title>
    <updated>2020-11-10T16:20:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/YhgGOHJnfCqqfWF_qp22oQ</id>
    <link href="https://mp.weixin.qq.com/s/YhgGOHJnfCqqfWF_qp22oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>松开肿瘤免疫环境的另一个刹车信号 ——抗TIGIT单克隆抗体</title>
    <updated>2020-11-09T19:13:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/1qUjHvb5Qri_yq7C2QjMcA</id>
    <link href="https://mp.weixin.qq.com/s/1qUjHvb5Qri_yq7C2QjMcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李进教授：PD-1、CLDN18.2靶点扎堆，从临床角度看抗癌新药机会何在？</title>
    <updated>2020-11-09T19:13:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/_NglRVM-a2-vkJ95kJuCxw</id>
    <link href="https://mp.weixin.qq.com/s/_NglRVM-a2-vkJ95kJuCxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>